Molecular Cardiology Research Institute, Tufts Medical Center, 800 Washington Street, Box # 80, Boston, MA, 02111, USA.
Surgical and Interventional Research Laboratories, Tufts Medical Center, 800 Washington Street, Box # 80, Boston, MA, 02111, USA.
J Cardiovasc Transl Res. 2019 Apr;12(2):87-94. doi: 10.1007/s12265-019-09876-3. Epub 2019 Apr 23.
Acute myocardial infarction (AMI) remains a leading cause of morbidity and mortality. Pioneering preclinical work reported by Peter Maroko and Eugene Braunwald in 1971 identified oxygen supply and demand are primary determinants of myocardial infarct size in the setting of a heart attack. Since the 1950s, advances in mechanical engineering led to the development of short-term circulatory support devices that range from pulsatile to continuous flow pumps. The primary objective of these pumps is to reduce native heart work, enhance coronary blood flow, and sustain systemic perfusion. Whether these pumps could reduce myocardial infarct size in the setting of AMI became an intense focus for preclinical investigation with variable animal models, experimental algorithms, and pump platforms being tested. In this review, we discuss the design of these preclinical studies and the evolution of mechanical support platforms and attempt to translate these experimental methods into clinical trials.
急性心肌梗死(AMI)仍然是发病率和死亡率的主要原因。Peter Maroko 和 Eugene Braunwald 于 1971 年开展的开创性临床前工作表明,在心脏病发作的情况下,氧的供应和需求是心肌梗死面积的主要决定因素。自 20 世纪 50 年代以来,机械工程的进步促使开发了短期循环支持设备,范围从脉动到连续流泵。这些泵的主要目的是减少原生心脏的工作量,增加冠状动脉血流量,并维持全身灌注。这些泵是否可以在 AMI 的情况下减少心肌梗死面积,成为临床前研究的一个重要焦点,各种动物模型、实验算法和泵平台都在进行测试。在这篇综述中,我们讨论了这些临床前研究的设计以及机械支持平台的发展,并尝试将这些实验方法转化为临床试验。